2 Results for "

Nanoformulation

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "Nanoformulation" in MCE Product Catalog:

Cat. No.: HY-154508
CAS No.: 134-46-3
Purity:  99.96%
Synonyms: 2’-Deoxy-5-Fluorouridine 5’-phosphate triethylammonium
FdUMP triethylammonium (2'-Deoxy-5-Fluorouridine 5'-phosphate triethylammonium) is the active metabolite nucleotide of 5-Fluorouracil (HY-90006), with an IC50 of 1.13 μM against human Thymidylate Synthase. FdUMP triethylammonium covalently inhibits the catalytic cycle of thymidylate synthase, blocking dTMP production, which in turn leads to inhibition of DNA synthesis. FdUMP triethylammonium can serve as a core active component of nanoformulations for cancer-related research, such as colorectal cancer, esophageal cancer, and hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-160713
CAS No.: 27297-42-3
Synonyms: NSSL-BMS
Betamethasone succinate (NSSL-BMS) is a nano-formulation that can cross the blood-brain barrier. Betamethasone succinate is prepared by encapsulating the Betamethasone (HY-13570) semi-succinate in PEG-liposomes. Betamethasone succinate utilizes the enhanced permeation and retention effects of liposomes to target and deliver the potent glucocorticoid to the inflammatory sites. Betamethasone succinate inhibits the secretion of pro-inflammatory cytokines (such as TNF-α and IL-6) while maintaining the level of anti-inflammatory cytokine TGF-β. Betamethasone succinate can be used in the research of arthritis and cerebral malaria .
loading...
    loading...